• 1
    Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189199.
  • 2
    Sanz MA, Sempere A. Immunophenotyping of AML and MDS and detection of residual disease. Baillieres Clin Haematol 1996; 9: 3555.
  • 3
    Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 1997; 71: 241319.
  • 4
    Lund-Johansen F, Terstappen LW. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 1993; 54: 4755.
  • 5
    Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ. Differentiation-associated changes in CD44 isoform expressing during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 1995; 86: 29762985.
  • 6
    Kansas GS, Murihead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 1990; 76: 24832492.
  • 7
    Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 1990; 75: 589595.
  • 8
    Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271335.
  • 9
    Koshiishi I, Shizari M, Underhill CB. CD44 can mediate the adhesion of platelets to hyaluronan. Blood 1994; 84: 390396.
  • 10
    Culty M, O'Mara TE, Underhill CB, Yeager H, Swartz RP. Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages. J Leukoc Biol 1994; 56: 605611.
  • 11
    Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincade PW. Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 1990; 171: 477488.
  • 12
    Gunji Y, Nakamure M, Hagiwara T, Hayakawa K, Matsushita H, Osawa H, Nagayoshi K, Nakauchi H, Yanagisawa M, Muira Y, Suda T. Expression and function of adhesion molecules on human hematopoietic stem cells: CD34+LFA-1- cells are more primitive than CD34+LFA-1+ cells. Blood 1992; 80: 429436.
  • 13
    Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992; 103: 293298.
  • 14
    Smadja-Joffe F, Legras S, Girard N, Li Y, Delpech B, Bloget F, Morimoto K, Le Bousse-Kerdiles C, Clay D, Jasmin C, Levesque JP. CD44 and hyaluronan-binding by human myeloid cells. Leuk Lymph 1996; 21: 407420.
  • 15
    Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257: 682685.
  • 16
    Weg-Remers S, Hildebrandt U, Feifel G, Moser C, Zeitz M, Stallmach A. Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6. Am J Gastroenterol 1998; 93: 790794.
    Direct Link:
  • 17
    Ristamaki R, Joensuu H, Jalkanen S. Does soluble CD44 reflect the clinical behavior of human cancer? Curr Top Microbiol Immunol 1996; 213: 155-166.
  • 18
    Van Driel M, Gunthert U, Stauder R, Joling P, Lokhorst HM, Bloem AC. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease. Leukemia 1998; 12: 18211828.
  • 19
    Legras S, Gunthert U, Stauder R, Curt F, Oliferenko S, Kluin-Nelemans HC, Marie JP, Proctor S, Jasmin C, Smadja-Joffe F. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998; 91: 34013413.
  • 20
    Nasu H, Hibi N, Ohyashiki JH, Hara A, Kubono K, Tsukada Y, Ando K, Iwama H, Hayashi S, Yahata N, Toyama K, Ohyashiki K. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes. Int J Oncol 1998; 13: 525530.
  • 21
    Charrad RS, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, Chomienne C, Smadja-Joffe F. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nature Med 1999; 5: 669676.
  • 22
    Elghetany MT. Surface marker abnormalities in myelodysplastic syndromes. Haematologica 1998; 83: 11041115.
  • 23
    Bonde J, Meyer K, Broe MK, Hokland M, Turley H, Hokland P. Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14, CD66 monoclonal antibodies. Br J Haematol 1996; 92: 269279.
  • 24
    Skubitz KM, Ducker TP, Goueli SA. CD66 monoclonal antibodies recognize a phosphotyrosine-containing protein bearing a carcinoembryonic antigen cross-reacting antigen on the surface of human neutrophils. J Immunol 1992; 148: 852860.
  • 25
    Hedley DW, Shankey TV, Wheeless LL. DNA cytometry consensus conference. Cytometry 1993; 14: 471500.
  • 26
    Soligo DA, Oriani A, Annaloro C, Cartelezzai A, Caloni R, Pozzoli E, Nosella D, Orazi A, Deliliery Gl. CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes. Am J Hematol 1994; 46: 917.
  • 27
    Pett MA. Nonparametric statistics for health care research. Thousand Oaks, CA: Sage Publications; 1997.
  • 28
    Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996; 87: 113.
  • 29
    Oertel J, Kleiner S, Huhn D. Immunotyping of blasts in refractory anemia with excess of blasts. Br J Haematol 1993; 84: 305309.
  • 30
    McKenna SL, Cotter TG. Functional aspects of apoptosis in hematopoiesis and consequences of failure. Adv Cancer Res 1997; 71; 121164.
  • 31
    Manaster J, Chezar J, Shurtz-Sversky R, Shapiro G, Tendler Y, Kristal B, Shasha SM, Sela S. Heparin induces apoptosis in human peripheral blood neutrophils. Br J Haematol 1996; 94: 4852.
  • 32
    Ohsaka A, Saionji K, Igari J, Watanabe N, Iwabuchi K, Nagaoka I. Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes. Br J Haematol 1997; l98: 108113.